DK1075512T3 - Cytotoxinbaseret biologisk indkapsling - Google Patents

Cytotoxinbaseret biologisk indkapsling

Info

Publication number
DK1075512T3
DK1075512T3 DK99917812.2T DK99917812T DK1075512T3 DK 1075512 T3 DK1075512 T3 DK 1075512T3 DK 99917812 T DK99917812 T DK 99917812T DK 1075512 T3 DK1075512 T3 DK 1075512T3
Authority
DK
Denmark
Prior art keywords
cytotoxin
based biological
biological encapsulation
encapsulation
biological
Prior art date
Application number
DK99917812.2T
Other languages
English (en)
Inventor
Kenn Gerdes
Peter Kristoffersen
Kim Pedersen
Marie Gotfredsen
Hugo Groenlund
Original Assignee
Univ Bruxelles
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Bruxelles filed Critical Univ Bruxelles
Application granted granted Critical
Publication of DK1075512T3 publication Critical patent/DK1075512T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/635—Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/68—Stabilisation of the vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK99917812.2T 1998-05-07 1999-05-07 Cytotoxinbaseret biologisk indkapsling DK1075512T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK62798 1998-05-07
US8506798P 1998-05-12 1998-05-12
PCT/DK1999/000258 WO1999058652A2 (en) 1998-05-07 1999-05-07 Cytotoxin-based biological containment

Publications (1)

Publication Number Publication Date
DK1075512T3 true DK1075512T3 (da) 2010-06-07

Family

ID=26064343

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99917812.2T DK1075512T3 (da) 1998-05-07 1999-05-07 Cytotoxinbaseret biologisk indkapsling

Country Status (7)

Country Link
US (3) US7183097B1 (da)
EP (2) EP2180050B1 (da)
AU (1) AU766257C (da)
CA (1) CA2327387C (da)
DE (1) DE69942249D1 (da)
DK (1) DK1075512T3 (da)
WO (1) WO1999058652A2 (da)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7176029B2 (en) 1992-07-31 2007-02-13 Universite Libre De Bruxelles Cloning and/or sequencing vector
BE1006085A3 (fr) 1992-07-31 1994-05-10 Univ Bruxelles Vecteur de clonage.
GB9916810D0 (en) * 1999-07-16 1999-09-22 Cancer Res Campaign Tech Killing cells
US6365129B1 (en) 1999-08-04 2002-04-02 Tosk, Inc. Invivo high throughput toxicology screening method
ATE439372T1 (de) * 2000-10-27 2009-08-15 Novartis Vaccines & Diagnostic Nukleinsäuren und proteine von gruppen a und b- streptokokken
CA2435956C (en) 2001-02-23 2012-07-10 Universite Libre De Bruxelles Method for the selection of recombinant clones comprising a sequence encoding an antidote protein to toxic molecule
US7780961B2 (en) 2001-05-03 2010-08-24 Actogenix N.V. Self-containing Lactococcus strain
US20090215179A1 (en) * 2001-07-20 2009-08-27 Transalgae Transgenically preventing establishment and spread of transgenic algae in natural ecosystems
AU2002366977A1 (en) 2002-01-02 2003-07-30 Jemtex Ink Jet Printing Ltd. Ink jet printing apparatus
US20050260585A1 (en) * 2002-03-19 2005-11-24 Cedric Szpirer Poison/antidote genetic systems for the selection of genetically modified eucaryote cells or organisms
WO2004001020A2 (en) 2002-06-19 2003-12-31 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Methods and means to promote gut absorption
US9309518B2 (en) 2002-09-03 2016-04-12 Universite Libre De Bruxelles Reversible, parallel and multitask cloning method and kit
AU2003260200A1 (en) 2002-09-03 2004-03-29 Universite Libre De Bruxelles Reversible, parallel and multitask cloning method and kit
US7491699B2 (en) 2002-12-09 2009-02-17 Ramot At Tel Aviv University Ltd. Peptide nanostructures and methods of generating and using the same
EP1583713B1 (en) 2003-01-07 2009-03-25 Ramot at Tel Aviv University Ltd. Peptide nanostructures encapsulating a foreign material and method of manufacturing same
JP2007527728A (ja) 2003-04-03 2007-10-04 ガリル メディカル リミテッド 正確に画定された冷凍切除のための装置及び方法
WO2005027901A1 (en) 2003-09-25 2005-03-31 Tel Aviv University Future Technology Development L.P. Compositions and methods using same for treating amyloid-associated diseases
WO2005031362A2 (en) * 2003-10-02 2005-04-07 Ramot At Tel Aviv University Ltd. Novel antibacterial agents and methods of identifying and utilizing same
WO2006013552A2 (en) 2004-08-02 2006-02-09 Ramot At Tel Aviv University Ltd. Articles of peptide nanostructures and method of forming the same
US7732479B2 (en) 2004-08-19 2010-06-08 Tel Aviv University Future Technology Development L.P. Compositions for treating amyloid associated diseases
WO2007024991A2 (en) * 2005-08-24 2007-03-01 University Of Medicine And Dentistry Of New Jersey Inhibition of mrna interferase-induced apoptosis in bak-deficient and bak-and bax-deficient mammalian cells
EP1973928A2 (en) 2005-10-11 2008-10-01 Ramot at Tel-Aviv University Ltd. Self-assembled fmoc-ff hydrogels
AU2006319216B2 (en) 2005-11-29 2012-09-13 Intrexon Actobiotics Nv Induction of mucosal tolerance to antigens
EP3351268B1 (en) 2007-01-25 2020-08-05 Intrexon Actobiotics NV Treatment of immune disease by mucosal delivery of antigens
CA2730741C (en) 2008-07-18 2016-10-25 Regis Sodoyer Self-replicating vector lacking an antibiotic-resistance gene
US8367392B2 (en) * 2008-09-05 2013-02-05 Transalgae Ltd. Genetic transformation of algal and cyanobacteria cells by microporation
EP2384366A4 (en) * 2008-09-05 2012-10-24 Jonathan Gressel TRANSGENIC PREVENTION OF THE ESTABLISHMENT AND PROPAGATION OF TRANSGENIC ALGAE IN NATURAL ECOSYSTEMS
US20110081706A1 (en) * 2009-10-02 2011-04-07 TransAlgae Ltd Method and system for efficient harvesting of microalgae and cyanobacteria
US9005977B2 (en) 2010-09-21 2015-04-14 Joule Unlimited Technologies, Inc. Methods and compositions for limiting viability of a modified host cell outside of designated process conditions
MX2013015327A (es) 2011-06-30 2014-01-31 Exxonmobil Res & Eng Co Regulacion de genes toxina y antitoxina para contencion biologica.
US9670504B2 (en) 2011-07-08 2017-06-06 Cilbiotech S.A. Transgenic system for reversibly immortalizing mammalian quiescent cells
WO2013067326A1 (en) * 2011-11-04 2013-05-10 University Of Georgia Research Foundation, Inc Methods for expressing polypeptides in hyperthermophiles
PT2814508T (pt) 2012-02-14 2017-07-19 Merial Inc Vacinas de subunidades de rotavírus e métodos para as produzir e uso das mesmas
WO2014145346A2 (en) * 2013-03-15 2014-09-18 Bacterial Robotics, Llc Compositions, systems and methods for protecting genetically modified organisms from unauthorized use or release into the environment
BR112016003533B1 (pt) 2013-08-19 2021-11-03 Syngulon Sa Célula microbiana geneticamente modificada e método para controlar o crescimento de uma segunda célula microbiana em um meio de cultura
WO2015118541A1 (en) * 2014-02-05 2015-08-13 Gavish-Galilee Bio Applications Ltd A genetic system for generating conditionally inactivated or attenuated bacteria
CN106715681B (zh) 2014-07-25 2021-08-24 R·P·谢勒科技有限责任公司 用于生产蛋白质的经改进的宿主细胞
WO2016073079A2 (en) * 2014-09-26 2016-05-12 Yale University Compositions and methods for biocontainment of microorganisms
EP3217807A4 (en) 2014-11-11 2018-09-12 Clara Foods Co. Methods and compositions for egg white protein production
CN111212569B (zh) 2017-08-31 2025-01-24 辛格隆股份公司 用于制备细菌素和抗微生物肽的方法和组合物
MY195280A (en) 2017-09-08 2023-01-12 New Portal Ltd Nucleic Acid Systems That Enable Bacteria to Specifically Target Solid Tumors Via Glucose-Dependent Viability
CA3084954A1 (en) 2017-12-05 2019-06-13 BioPlx, Inc. Methods and compositions to prevent microbial infection
WO2019121983A1 (en) 2017-12-19 2019-06-27 Syngulon S.A. Fermentation process
BR112020024767A2 (pt) 2018-06-06 2021-03-23 Syngulon Sa engenharia de peptídeos antimicrobianos
SI3997118T1 (sl) 2019-07-11 2025-06-30 Clara Foods Co. Sestavek napitka, ki obsega rekombinantni ovomukoidni protein
US12096784B2 (en) 2019-07-11 2024-09-24 Clara Foods Co. Protein compositions and consumable products thereof
US10927360B1 (en) 2019-08-07 2021-02-23 Clara Foods Co. Compositions comprising digestive enzymes
US11149280B2 (en) 2019-10-29 2021-10-19 Yale University Engineering organisms resistant to viruses and horizontally transferred genetic elements
CN111429969A (zh) * 2020-03-31 2020-07-17 中国人民解放军军事科学院军事医学研究院 一种细菌中功能性前噬菌体及其位置与序列的检测方法
WO2022006748A1 (en) 2020-07-07 2022-01-13 New Portal Limited Genetically engineered live bacteria and methods of constructing the same
CN118374547A (zh) * 2023-01-13 2024-07-23 上海吉量医药工程有限公司 一种无抗微质粒及其制备方法和应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE107697T1 (de) * 1986-03-26 1994-07-15 Genexpress Aps Biologische eindämmung.
US5464764A (en) 1989-08-22 1995-11-07 University Of Utah Research Foundation Positive-negative selection methods and vectors
US5300431A (en) 1991-02-26 1994-04-05 E. I. Du Pont De Nemours And Company Positive selection vector for the bacteriophage P1 cloning system
US7176029B2 (en) 1992-07-31 2007-02-13 Universite Libre De Bruxelles Cloning and/or sequencing vector
BE1006085A3 (fr) 1992-07-31 1994-05-10 Univ Bruxelles Vecteur de clonage.
CA2173751A1 (en) 1993-10-13 1995-04-20 Sýren Molin Recombinant staphylococcal nucleases and their use in limiting the survival of genetically engineered microorganisms
JP2590761B2 (ja) 1994-11-22 1997-03-12 日本電気株式会社 Ｔａｂ式半導体装置およびｔａｂ式半導体装置を回路基板に接続する方法
NZ500843A (en) 1995-06-07 2002-03-28 Invitrogen Corp A method of DNA recombination which is selectable to select for cells containing a product and against cells only harbouring the insert donor
US6143557A (en) 1995-06-07 2000-11-07 Life Technologies, Inc. Recombination cloning using engineered recombination sites
NZ322673A (en) 1995-10-13 1999-09-29 Purdue Research Foundation Method for the production of hybrid plants
US5922583A (en) 1995-10-17 1999-07-13 Biostar Inc. Methods for production of recombinant plasmids
JP4303418B2 (ja) 1997-10-24 2009-07-29 ライフ テクノロジーズ コーポレーション 組換え部位を有する核酸を使用する組換えクローニング
US6271359B1 (en) 1999-04-14 2001-08-07 Musc Foundation For Research Development Tissue-specific and pathogen-specific toxic agents and ribozymes
NZ529476A (en) 1999-10-25 2005-03-24 Invitrogen Corp Methods of manipulating and sequencing nucleic acid molecules using transposition and recombination
CN1757724B (zh) 1999-12-10 2014-06-11 茵维特罗根公司 具有独特特异性的多个重组位点在重组克隆中的用途
EP1111061A1 (en) 1999-12-20 2001-06-27 Universite Libre De Bruxelles Double selection vector
DE10038573A1 (de) 2000-08-03 2002-02-21 Mpb Cologne Gmbh Molecular Pla Verfahren zur Selektion auf Wirtszellen mit eliminierten DNA-Sequenzen
CA2435956C (en) 2001-02-23 2012-07-10 Universite Libre De Bruxelles Method for the selection of recombinant clones comprising a sequence encoding an antidote protein to toxic molecule
US20050260585A1 (en) 2002-03-19 2005-11-24 Cedric Szpirer Poison/antidote genetic systems for the selection of genetically modified eucaryote cells or organisms
AU2003260200A1 (en) 2002-09-03 2004-03-29 Universite Libre De Bruxelles Reversible, parallel and multitask cloning method and kit
US20050130306A1 (en) * 2003-12-10 2005-06-16 Richard Voellmy Viral vectors whose replication and, optionally, passenger gene are controlled by a gene switch activated by heat in the presence or absence of a small molecule regulator

Also Published As

Publication number Publication date
US20080182327A1 (en) 2008-07-31
AU766257B2 (en) 2003-10-09
EP1075512A2 (en) 2001-02-14
CA2327387C (en) 2012-07-03
EP2180050A3 (en) 2010-06-30
EP2180050B1 (en) 2016-04-20
DE69942249D1 (de) 2010-05-27
US7183097B1 (en) 2007-02-27
WO1999058652A2 (en) 1999-11-18
EP2180050A2 (en) 2010-04-28
AU766257C (en) 2004-06-03
US7595185B2 (en) 2009-09-29
EP1075512B1 (en) 2010-04-14
AU3596399A (en) 1999-11-29
US7595186B2 (en) 2009-09-29
CA2327387A1 (en) 1999-11-08
US20080206840A1 (en) 2008-08-28
WO1999058652A3 (en) 2000-01-20

Similar Documents

Publication Publication Date Title
DE69829040D1 (de) Elektroplattierungschemie
DE59914158D1 (de) Metallocenmonohalogenide
ATE341990T1 (de) Sigmidoskop
DE69904211D1 (de) Polyalkoxylierte naphtopyrans
DE69904595D1 (de) Betacarbolinverbindungen
DE59911453D1 (de) Aktivkohlefilter
DE59912371D1 (de) Gleitschalungsfertiger
DE69835302D1 (de) Tintenbehälternachfüllsystem
DE59901560D1 (de) Retrograder tibianagel
DE69901661D1 (de) Fahrzeugnutzsitz
DE59907306D1 (de) Fadenchangierung
DE59906931D1 (de) Exzenterzahnradgetriebe
DE59911683D1 (de) Fahrzeugschliessanlage
DE69902034D1 (de) Lattenkollimator
DE69901068D1 (de) Estersynthese
DE69902880D1 (de) Resonanzumwandlerschaltung
DE69811890D1 (de) Einzellenkalorimeter
DE69904737D1 (de) Streifenkodelesegerät
DE69901852D1 (de) Perfluorodioxolen
DE59903966D1 (de) Exzenterzahnradgetriebe
DE59908968D1 (de) Benzoylpyridazine
DE69904766D1 (de) Kodenübersetzer
DE59913393D1 (de) Fadenchangierung
DE69827358D1 (de) Weglenkungsverfahren
DE59908057D1 (de) Underdruckhandhabungseinrichung